RBC Capital Maintains Edwards Lifesciences(EW.US) With Buy Rating, Cuts Target Price to $85
RBC Capital Reaffirms Their Buy Rating on Edwards Lifesciences (EW)
Options Market Statistics: Walmart Stock Rallies, Options Pop on Q2 Earnings Beat, Raised View
Edwards Lifesciences Options Spot-On: On August 15th, 72,829 Contracts Were Traded, With 94,815 Open Interest
Unusual Options Activity: EW, APTV and Others Attract Market Bets, EW V/OI Ratio Reaches 460.4
Why You Should Care About Edwards Lifesciences' (NYSE:EW) Strong Returns On Capital
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
